Clinical Reference Laboratory strengthens position in Asia

Integrates long-term partner Phoenix Pharma Central Services in Singapore

Clinical Reference Laboratory (CRL), a US-based provider of central laboratory services for clinical trials with a European operation in Cambridge, UK, has fully integrated its long-standing laboratory partner Phoenix Pharma Central Services in Singapore.

CRL says the addition of Phoenix’s testing platforms into its Global LIMSystem enhances CRL’s support of clinical trials in Asia through improved efficiencies, increased quality, reduced costs and full global project oversight. It also further builds on Phoenix’s experienced management team, experience of the Asian market and domain knowledge in clinical trials.

CRL’s chief executive Tim Sotos said: ‘We have a trusted relationship with Phoenix, having worked together for over a decade supporting a large number of clinical trials globally.

‘By incorporating Phoenix’s data into our centralised Global LIMSystem it allows for both sites and clinical teams to access data throughout the world using CRL’s proprietary web-based Oasis systems. This provides drug development companies with direct oversight on the status of their trial and allows them to evaluate drug safety on a real-time basis.’

Companies